<!DOCTYPE html>
<html lang="en-US"><head>
		<meta charset="UTF-8">
		<title>FR940412-1-00024</title>
	</head>
	<body>
		<main>
			<p><!-- PJG STAG 4702 -->  <!-- PJG ITAG l=80 g=1 f=1 --> &sect;4.86a  <!-- PJG /ITAG -->  <!-- PJG ITAG l=89 g=1 f=1 --> [Removed] <!-- PJG 0012 frnewline -->  <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=1 f=1 --> 4. Section 4.86a is removed. <!-- PJG 0012 frnewline --> 5. Section 4.87 is revised to read as follows: <!-- PJG 0012 frnewline -->  <!-- PJG /ITAG -->  <!-- PJG ITAG l=80 g=1 f=1 --> &sect;4.87  <!-- PJG /ITAG -->  <!-- PJG ITAG l=89 g=1 f=1 --> Schedule of ratings_ear. <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline -->  <!-- PJG /ITAG -->  <TABLE>  <!-- PJG tableformat 2,L2,tp0,i1,s25,7 -->  <!-- PJG 0012 frnewline -->  <!-- PJG ITAG l=95 g=1 f=1 --> &blank; <!-- PJG 0012 frnewline -->  <!-- PJG 007 0150 intable --> 1&blank;  <!-- PJG 007 0150 intable --> 1Rating <!-- PJG 007 0152 intable -->  <!-- PJG /ITAG -->  <!-- PJG QTAG 03 --> <!-- PJG /QTAG -->  <!-- PJG 0012 frnewline -->  <!-- PJG ITAG l=21 g=1 f=1 -->  <!-- PJG /ITAG -->  <!-- PJG ITAG l=21 g=1 f=2 --> Diseases of the Ear <!-- PJG /ITAG -->  <!-- PJG QTAG 02 --> <!-- PJG /QTAG -->  <!-- PJG 0012 frnewline -->  <!-- PJG ITAG l=11 g=1 f=2 --> 6200&blank;Chronic suppurative otitis media including cholesteatoma or mastoiditis <!-- PJG 0012 frnewline -->  <!-- PJG /ITAG -->  <!-- PJG ITAG l=01 g=1 f=2 --> During suppuration  <!-- PJG 007 0104 intable --> 10 <!-- PJG 0012 frnewline -->  <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=1 f=2 --> Note:  <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=1 f=1 --> Loss of hearing shall be separately rated and combined. <!-- PJG 0012 frnewline --> 6201&blank;Chronic otitis media with effusion (serous otitis media) <!-- PJG 0012 frnewline --> Rate loss of hearing. <!-- PJG 0012 frnewline -->  <!-- PJG /ITAG -->  <!-- PJG ITAG l=22 g=1 f=1 --> 6202&blank;Otosclerosis <!-- PJG 0012 frnewline --> Rate loss of hearing. <!-- PJG 0012 frnewline --> 6204&blank;Peripheral vestibular disorders <!-- PJG 0012 frnewline -->  <!-- PJG /ITAG -->  <!-- PJG ITAG l=01 g=1 f=1 --> Dizziness and occasional staggering  <!-- PJG 007 0104 intable --> 30 <!-- PJG 0012 frnewline --> Occasional dizziness  <!-- PJG 007 0104 intable --> 10 <!-- PJG 0012 frnewline -->  <!-- PJG /ITAG -->  <!-- PJG ITAG l=22 g=1 f=1 -->  <!-- PJG /ITAG -->  <!-- PJG ITAG l=22 g=1 f=2 --> Note:  <!-- PJG /ITAG -->  <!-- PJG ITAG l=22 g=1 f=1 --> Objective findings supporting the diagnosis of vestibular disequilibrium are required before a compensable evaluation can be assigned under this code. Loss of hearing or suppuration shall be separately rated and combined. <!-- PJG 0012 frnewline -->  <!-- PJG /ITAG -->  <!-- PJG ITAG l=01 g=1 f=1 --> 6205&blank;Meniere's syndrome (endolymphatic hydrops) Deafness with attacks of vertigo and cerebellar gait occurring more than once weekly  <!-- PJG 007 0104 intable --> 100 <!-- PJG 0012 frnewline --> Deafness with attacks of vertigo and cerebellar gait occurring once a week or less  <!-- PJG 007 0104 intable --> 60 <!-- PJG 0012 frnewline --> Deafness with occasional vertigo  <!-- PJG 007 0104 intable --> 30 <!-- PJG 0012 frnewline -->  <!-- PJG /ITAG -->  <!-- PJG ITAG l=22 g=1 f=1 --> 6207&blank;Loss of auricle: <!-- PJG 0012 frnewline -->  <!-- PJG /ITAG -->  <!-- PJG ITAG l=01 g=1 f=1 --> Complete loss of both  <!-- PJG 007 0104 intable --> 50 <!-- PJG 0012 frnewline --> Complete loss of one  <!-- PJG 007 0104 intable --> 30 <!-- PJG 0012 frnewline --> Deformity of one, with loss of one-third or more of the substance  <!-- PJG 007 0104 intable --> 10 <!-- PJG 0012 frnewline --> 6208&blank;Malignant neoplasm of the ear, (other than skin only)  <!-- PJG 007 0104 intable --> 100 <!-- PJG 0012 frnewline -->  <!-- PJG /ITAG -->  <!-- PJG ITAG l=22 g=1 f=1 -->  <!-- PJG /ITAG -->  <!-- PJG ITAG l=22 g=1 f=2 --> Note:  <!-- PJG /ITAG -->  <!-- PJG ITAG l=22 g=1 f=1 --> Following the cessation of surgical, X-ray, antineoplastic or other therapeutic procedure, the rating of 100 percent shall continue with a mandatory VA examination at the expiration of six months. Any change in evaluation based upon that examination shall be subject to the provisions of &sect;3.105(e) of this chapter. If there has been no local recurrence or metastasis, rate on residual impairment of function. <!-- PJG 0012 frnewline --> 6209&blank;Benign neoplasms of the ear, (other than skin only) <!-- PJG 0012 frnewline --> Rate on impairment of function <!-- PJG 0012 frnewline -->  <!-- PJG /ITAG -->  <!-- PJG ITAG l=01 g=1 f=1 --> 6210&blank;Chronic otitis externa swelling, dry and scaly or serous discharge and itching requiring frequent and prolonged treatment  <!-- PJG 007 0104 intable --> 10 <!-- PJG 0012 frnewline --> 6211&blank;Tympanic membrane, perforation of  <!-- PJG 007 0104 intable --> 0 <!-- PJG 0012 frnewline --> 6260&blank;Tinnitus, recurrent  <!-- PJG 007 0104 intable --> 10 <!-- PJG 0012 frnewline -->  <!-- PJG /ITAG -->  </TABLE>  <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline -->  <!-- PJG ITAG l=11 g=1 f=1 --> 6. Section 4.87a is revised to read as follows: <!-- PJG 0012 frnewline -->  <!-- PJG /ITAG -->  <!-- PJG ITAG l=80 g=1 f=1 --> &sect;4.87a  <!-- PJG /ITAG -->  <!-- PJG ITAG l=89 g=1 f=1 --> Schedule of ratings_other sense organs. <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline -->  <!-- PJG /ITAG -->  <TABLE>  <!-- PJG tableformat 2,L0,tp0,p0,8/9,i1,s15,7 -->  <!-- PJG 0012 frnewline -->  <!-- PJG ITAG l=95 g=1 f=1 --> &blank; <!-- PJG 0012 frnewline -->  <!-- PJG 007 0150 intable --> 1&blank;  <!-- PJG 007 0150 intable --> 1&blank; <!-- PJG 007 0152 intable -->  <!-- PJG /ITAG -->  <!-- PJG QTAG 03 --> <!-- PJG /QTAG -->  <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline -->  <!-- PJG ITAG l=01 g=1 f=1 --> 6275&blank;Sense of smell, complete loss  <!-- PJG 007 0104 intable --> 10 <!-- PJG 0012 frnewline --> 6276&blank;Sense of taste, complete loss  <!-- PJG 007 0104 intable --> 10 <!-- PJG /ITAG -->  </TABLE>  <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline -->  <!-- PJG ITAG l=21 g=1 f=1 -->  <!-- PJG /ITAG -->  <!-- PJG ITAG l=21 g=1 f=4 --> Note:  <!-- PJG /ITAG -->  <!-- PJG ITAG l=21 g=1 f=1 --> These ratings will be assigned only if there is an anatomical or pathological basis for the condition. <!-- PJG 0012 frnewline -->  <!-- PJG /ITAG -->  <!-- PJG ITAG l=80 g=1 f=1 --> &sect;4.87b  <!-- PJG /ITAG -->  <!-- PJG ITAG l=89 g=1 f=1 --> [Removed] <!-- PJG 0012 frnewline -->  <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=1 f=1 --> 7. Section 4.87b is removed. <!-- PJG /ITAG -->  <!-- PJG QTAG 03 --> <!-- PJG /QTAG -->  <!-- PJG 0012 frnewline -->  <FRFILING> <!-- PJG ITAG l=40 g=1 f=1 --> [FR Doc. 94&hyph;8555 Filed 4&hyph;11&hyph;94; 8:45 am] <!-- PJG 0012 frnewline -->  <!-- PJG /ITAG --> </FRFILING> <BILLING> <!-- PJG ITAG l=68 g=1 f=1 --> BILLING CODE 8320&hyph;01&hyph;P <!-- PJG /ITAG --> </BILLING>  <!-- PJG 0012 frnewline -->  <!-- PJG /STAG --></p>
		</main>
</body></html>
            